Deep brain stimulation of the subthalamic nucleus reduces antiparkinsonian medication costs

Parkinsonism and Related Disorders

Volumn 10, Issue 8, 2004, Pages 475-479

  David Charles, P ^a   Padaliya, Bimal B ^b   Newman, William J ^b   Gill, Chandler E ^a   Covington, Cassondra D ^a   Fang, John Y ^a   So, Stephanie A ^b   Tramontana, Michael G ^b   Konrad, Peter E ^b   Davis, Thomas L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Antiparkinsonian medications; Cost analysis; Deep brain stimulation; Parkinson's disease; Subthalamic nucleus

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG COST; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

AMANTADINE; ANTIPARKINSON AGENTS; CATECHOL O-METHYLTRANSFERASE; COMBINED MODALITY THERAPY; DEEP BRAIN STIMULATION; DRUG COSTS; ELECTRODES, IMPLANTED; ENZYME INHIBITORS; HUMANS; LEVODOPA; MODELS, ECONOMIC; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SUBTHALAMIC NUCLEUS;

EID: 20844458091     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2004.05.006     Document Type: Article

References (31)

1. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., Benabid A.L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 339:1998;1105-1111
2. The Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med. 345:2001;956-963
3. Krack P., Limousin P., Benabid A.L., Pollak P. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet. 350:1997;1676
4. Lopiano L., Rizzone M., Bergamasco B., Tavella A., Torre E., Perozzo P., Valentini M.C., Lanotte M. Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology. 56:2001;552-554
5. Ostergaard K., Sunde N., Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord. 17:2002;693-700
6. Bejjani B.P., Dormont D., Pidoux B., Yelnik J., Damier P., Arnule I., Bonnet A.M., Marsault C., Agid Y., Philippon J., Cornu P. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg. 92:2000;615-625
7. Kumar R., Lozano A.M., Kim Y.J., Hutchinson W.D., Sime E., Halket E., Lang A.E. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology. 51:1998;850-855
8. Rodriguez-Oroz M.C., Gorospe A., Guridi J., Ramos E., Linazasoro G., Rodriquez-Palmero M., Obeso J.A. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurology. 55:2000;S45-S51
9. Benabid A.L., Koudsié A., Benazzouz A., Vercueil L., Fraix V., Chabardes S., Lebas J.F., Pollak P. Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy. J Neurol. 248:2001;III/37-III/47
10. Molinuevo J.L., Valldeoriola F., Tolosa E., Rumia J., Valls-Sole J., Roldan H., Ferrer E. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol. 57:2000;983-988
11. Pinter M.M., Alesch F., Murg M., Seiwald M., Helscher R.J., Binder H. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson's disease: one year follow-up. J Neural Transm. 106:1999;693-709
12. Pinter M.M., Alesch F., Murg M., Helscher R.J., Binder H. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol. 246:1999;907-913
13. Spottke E.A., Volkmann J., Lorenz D., Krack P., Smala A.M., Sturm V., Gerstner A., Berger K., Hellwig D., Deuschl G., Freund H.J., Oertel W.H., Dodel R.C. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. J Neurol. 249:2002;759-766
14. Tomaszewski K.J., Holloway R.G. Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis. Neurology. 57:2001;663-671
15. Moro E., Scerrati M., Romito A., Roselli R., Tonali P., Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology. 53:1999;85-90
16. Thobois S., Mertens P., Guenot M., Hermier M., Mollion H., Bouvard M., Chazot G., Broussolle E., Sindou M. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol. 249:2002;529-534
17. Houeto J.L., Damier P., Bejjani P.B., Staedler C., Bonnet A.M., Arnulf I., Pidoux B., Dormont D., Cornu P., Agid Y. Subthalamic stimulation in Parkinson disease. Arch Neurol. 57:2000;461-465
18. Vingerhoets F.J.G., Villemure J.G., Temperli P., Pollo C., Pralong E., Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology. 58:2002;396-401
19. Benabid A.L., Krack P., Benazzouz A., Limousin P., Koudsie A., Pollak P. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology. 55:2000;S40-S44
20. Tavella A., Bergamasco B., Bosticco E., Lanotte M., Perozzo P., Rizzone M., Torre E., Lopiano L. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long term follow-up. Neurol Sci. 23:2002;S111-S112
21. Krack P., Pollak P., Limousin P., Hoffman D., Xie J., Benazzouz A., Benabid A.L. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain. 121:1998;451-457
22. Simuni T., Jaggi J.L., Mulholland H., Hurtig H.I., Colcher A., Siderowf D., Ravina B., Skolnick B.E., Goldstein R., Stern M.B., Baltuch G.H. Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg. 96:2002;666-672
23. Starr P.A., Christine C.W., Theodosopoulos P.V., Lindsey N., Byrd D., Mosley A., Marks W.J. Jr. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg. 97:2002;370-387
24. Lozano A., Hutchinson W., Kiss Z., Tasker R., Davis K., Dostrovsky J. Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg. 84:1996;194-202
25. Hutchinson W., Allan R., Opitz H., Levy R., Dostrovsky J.O., Lang A.E., Lozano A.M. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol. 44:1998;622-628
26. Vitek J., Bakay R., Hashimoto T., Kaneoke Y., Mewes K., Zhang J.Y., Rye D., Starr P., Baron M., Turner R., DeLong M.R. Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. J Neurosurg. 88:1998;1027-1043
27. Medical Economics Co. Drug topics red book. 2002;Medical Economics Co, Montvale, NJ
28. McColl C.D., Reardon K.A., Shiff M., Kempster P.A. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. Mov Disord. 17:2002;1227-1234
29. Goetz C.G., Stebbins G.T., Blasucci L.M. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord. 15:2000;479-484
30. Reardon K.A., Shiff M., Kempster P.A. Evolution of motor fluctuations in Parkinson's disease: a longitudinal study over 6 years. Mov Disord. 14:1999;605-611
31. Rascol O., Payoux P., Ory F., Ferreira J.J., Brefel-Courbon C., Montastruc J.-L. Limitations of current Parkinson's disease therapy. Ann Neurol. 53:2003;S3-S15